These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 12215312

  • 1. DES exposure and the aging woman: mothers and daughters.
    Laitman CJ.
    Curr Womens Health Rep; 2002 Oct; 2(5):390-3. PubMed ID: 12215312
    [Abstract] [Full Text] [Related]

  • 2. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [Abstract] [Full Text] [Related]

  • 3. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA.
    Int J Fertil; 1989 Feb; 34(4):251-5. PubMed ID: 2570761
    [Abstract] [Full Text] [Related]

  • 4. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL.
    Princess Takamatsu Symp; 1987 Feb; 18():67-75. PubMed ID: 3506546
    [Abstract] [Full Text] [Related]

  • 5. The current status of the DES-exposed population.
    Herbst AL.
    Obstet Gynecol Annu; 1981 Feb; 10():267-78. PubMed ID: 7024873
    [Abstract] [Full Text] [Related]

  • 6. DES exposure: implications for childbearing.
    Milhan D.
    Int J Childbirth Educ; 1992 Feb; 7(4):21-8. PubMed ID: 12286762
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epidemiological studies of the effects of diethylstilboestrol.
    Vessey MP.
    IARC Sci Publ; 1989 Feb; (96):335-48. PubMed ID: 2680951
    [Abstract] [Full Text] [Related]

  • 9. [Fertility disorders attributable to the use of diethylstilbestrol during intrauterine life].
    Drapier E.
    Rev Fr Gynecol Obstet; 1984 Apr; 79(4):297-300, 303-5. PubMed ID: 6397835
    [Abstract] [Full Text] [Related]

  • 10. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL.
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [Abstract] [Full Text] [Related]

  • 11. Management of the adolescent girl exposed in utero to DES.
    Gerbie MV.
    Pediatr Ann; 1981 Dec; 10(12):23-6. PubMed ID: 7335401
    [Abstract] [Full Text] [Related]

  • 12. Diethylstilbestrol: risks of malignant disease and congenital malformations.
    Kinch RA.
    Can Med Assoc J; 1979 Jun 23; 120(12):1483-4. PubMed ID: 455196
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem].
    Treffers PE, Hanselaar AG, Helmerhorst TJ, Koster ME, van Leeuwen FE.
    Ned Tijdschr Geneeskd; 2001 Apr 07; 145(14):675-80. PubMed ID: 11530703
    [Abstract] [Full Text] [Related]

  • 17. Diethylstilbestrol exposure.
    Schrager S, Potter BE.
    Am Fam Physician; 2004 May 15; 69(10):2395-400. PubMed ID: 15168959
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clear cell renal carcinoma in a pregnant DES-exposed patient.
    Mansi ML.
    J Am Osteopath Assoc; 1989 Jul 15; 89(7):929-32. PubMed ID: 2768009
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.